Shareholders Equity (Annual)

Shareholders Equity: The sum of preferred and common equity items.

ResMed Inc. (RMD) had Shareholders Equity of $6.59B for the most recently reported fiscal year, ending 2026-06-30.

Quarterly Annual

Figures for fiscal year ending 2026-06-30

Income Statement Financials
Revenue	$5.65B
Net Income	$1.52B
Cost of Goods Sold	$2.20B
Gross Profit	$3.45B
Operating Expenses	$3.77B
Operating Income	$1.89B
Non-Operating Income/Expense	$32.70M
Pre-Tax Income	$1.92B
Normalized Pre-Tax Income	$1.92B
Income after Taxes	$1.52B
Income from Continuous Operations	$1.52B
Consolidated Net Income/Loss	$1.52B
Normalized Income after Taxes	$1.52B
EBIT	$1.89B
EBITDA	$2.13B
Weighted-Average Shares Outstanding (Basic)	145.52M
Weighted-Average Shares Outstanding (Diluted)	146.05M
Earnings per Share (EPS) (Basic)	$10.47
Earnings per Share (EPS) (Diluted)	$10.43
Balance Sheet Financials
Current Assets	$4.32B
Property, Plant, and Equipment	$581.83M
Long-Term Assets	$4.64B
Total Assets	$8.97B
Current Liabilities	$1.40B
Long-Term Debt	$399.42M
Long-Term Liabilities	$985.45M
Total Liabilities	$2.38B
Common Equity	$6.59B
Tangible Shareholders Equity	$3.22B
Shareholders Equity	$6.59B
Common Shares Outstanding	144.24M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.81B
Cash Flow from Investing Activities	$-545.20M
Cash Flow from Financial Activities	$-1.01B
Beginning Cash	$1.21B
End Cash	$1.47B
Increase/Decrease in Cash	$259.78M
Stock-Based Compensation	$104.35M
Common Stock Dividends Paid	$-349.66M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.10
Gross Margin	61.06%
Operating Margin	33.37%
EBIT Margin	33.37%
EBITDA Margin	37.69%
Pre-Tax Profit Margin	33.95%
Profit Margin	26.94%
Free Cash Flow	$1.65B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.63
Inventory Turnover	2.33
Receiveable Turnover	5.46
Days Sales in Receivables	66.90
Return on Equity	23.13%
Return on Tangible Equity	47.26%
Return on Assets	16.99%
Return on Investments	21.81%
Book Value Per Share	$45.66
Free Cash Flow per Share	$11.29
Operating Cash Flow per Share	$12.36

Data from Zacks Investment Research, Inc.